about
Acid beta-glucosidase 1 counteracts p38delta-dependent induction of interleukin-6: possible role for ceramide as an anti-inflammatory lipidInvolvement of acid beta-glucosidase 1 in the salvage pathway of ceramide formationReduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's diseaseThe sphingolipid salvage pathway in ceramide metabolism and signalingCeramide as a Target of Marine Triterpene Glycosides for Treatment of Human Myeloid LeukemiaMetabolic manipulation of glycosylation disorders in humans and animal modelsAdult ceramide synthase 2 (CERS2)-deficient mice exhibit myelin sheath defects, cerebellar degeneration, and hepatocarcinomas.Synthesis of reference standards to enable single cell metabolomic studies of tetramethylrhodamine-labeled ganglioside GM1.An introduction to sphingolipid metabolism and analysis by new technologiesMulti-system disorders of glycosphingolipid and ganglioside metabolismUse of lissamine rhodamine ceramide trihexoside as a functional assay for alpha-galactosidase A in intact cellsEndosomal/lysosomal processing of gangliosides affects neuronal cholesterol sequestration in Niemann-Pick disease type C.Secondary lipid accumulation in lysosomal disease.Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics.Ganglioside biochemistryGlucocerebrosidase Deficiency in Drosophila Results in α-Synuclein-Independent Protein Aggregation and Neurodegeneration.Activities of genes controlling sphingolipid metabolism in human fibroblasts treated with flavonoids.Storage solutions: treating lysosomal disorders of the brain.Gangliosides as apoptotic signals in ER stress response.Leishmania major UDP-sugar pyrophosphorylase salvages galactose for glycoconjugate biosynthesisPathogenic cascades in lysosomal disease-Why so complex?Myelin lesions associated with lysosomal and peroxisomal disorders.Lysosomal lipid storage diseases.Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer.Allylic structures in cancer drugs and body metabolites that control cell life and death.Sphingolipids: key regulators of apoptosis and pivotal players in cancer drug resistanceRole of Sphingolipids and Metabolizing Enzymes in Hematological Malignancies.Platelet-derived sphingosine-1-phosphate and inflammation: from basic mechanisms to clinical implications.Blood-brain barrier shuttle peptides: an emerging paradigm for brain delivery.Sustained activation of sphingomyelin synthase by 2-hydroxyoleic acid induces sphingolipidosis in tumor cells.Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinson’s disease.Evidence for a role of glycosphingolipids in CXCR4-dependent cell migration.Sphingolipids are necessary for nicotinic acetylcholine receptor export in the early secretory pathway.Abl family tyrosine kinases regulate sialylated ganglioside receptors for polyomavirus.Effect of glycosphingolipids on osteoclastogenesis and osteolytic bone diseases.Sphingosine 1-phosphate (S1P) lyase deficiency increases sphingolipid formation via recycling at the expense of de novo biosynthesis in neuronsThe many faces (and phases) of ceramide and sphingomyelin I - single lipids.Mitochondrial permeability transition induced by reactive oxygen species is independent of cholesterol-regulated membrane fluidity.Translational Aspects of Sphingolipid Metabolism in Renal Disorders.γ-Tocotrienol induces apoptosis in pancreatic cancer cells by upregulation of ceramide synthesis and modulation of sphingolipid transport.
P2860
Q24320202-A63983A3-4056-4736-A3D2-15FF4839DFC3Q24320259-64EB6DC0-E3EB-4797-96A1-5D2E8AAAC779Q24324577-316CDF9F-25F0-4DDA-9AFB-65C937744050Q24642219-B7356F62-928B-4E7C-A92A-91AB3ABDF001Q28074507-A8B02F4D-D2BC-42A8-81AC-1B7466560E73Q28749888-70E6749D-2D21-42AA-8EF3-BBB59E8C8B90Q30492014-D41D83D7-E18C-4639-8C48-57B563E2C9FAQ33261868-DD9D700F-4FDB-47EF-81AD-219E1A1106F6Q33648081-FF0785DC-931D-4A3F-A2A2-9E86FEA602CFQ33902037-7D1266A5-7CB9-489E-9397-903AE7BF5D18Q34053196-7F829638-7654-4D2F-9DD6-9F04C485A3DBQ35167848-15CC6485-8633-4F06-A373-649A0E98DE15Q35240940-518C591E-6A32-4A29-B68D-383B102AEA57Q35324757-887FB741-B26E-4BD4-A8FF-9B0D47D15158Q35361488-CA69587A-69C3-4D5F-AEBF-8C941C68DD53Q35971649-40C45E26-36A0-4B3B-A111-8537A0096EF9Q36030017-24022BAD-DAC0-4091-BB8F-585D8527080DQ36210235-392D725F-FDDE-4B33-ADA3-A795835F8602Q36362402-0F4B4AE7-1F78-48F5-B15D-5F4664152547Q36488276-C6B87F06-A7A8-436A-B1D1-C77868B95EECQ37364596-FB7A8A89-B02B-41F3-B342-8B60A922B48EQ37785556-09EBE83A-F034-40FA-8DF7-8EB609E21B2EQ37866549-C5FF3A63-006F-4EB2-AAE0-344A72E833D7Q38052818-5523F1B5-06AB-4BDE-961E-7A534EC5A204Q38089154-4190FE27-7345-4D5E-ACD8-1368E6BBACF1Q38195691-4F6DE3D6-657A-4A7E-AF6F-255E18AC0797Q38495744-23660902-2BC4-4AC9-9B0E-A30A9AF09E2BQ38763707-D535A99B-5A20-4668-B53A-F4FFB59CF21FQ38836486-C11A3005-B13D-4E06-BFE7-01A82A6A7D06Q39183511-DFE97978-4C90-492E-8E2F-25F5E935E1A3Q39193441-8F9DB6F8-63DB-4B6E-99AE-5C66DE1868BEQ40130983-E3632E2F-D2E0-4E2F-A6D8-7C956B1276A2Q40145216-37525E55-F7D6-4D5F-9F56-4310EA074183Q40338662-0883A80E-BB6D-476C-903F-5E5DB467240AQ42288514-5544B3A4-90BC-4EA1-9BC2-D79FA5FE83FBQ42575213-EC988DE3-0244-4823-A9E9-3A856B56141DQ44162702-F94D95F7-E4AC-4811-A1F1-696C45D3F227Q44779063-1AB5620B-48CD-43D7-8422-4411E75F0610Q49399657-A4D770D1-BE99-4463-8644-423B6F3A62CBQ55332868-E1C1513B-C853-456E-BBB8-15F5AE939480
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Salvage pathways in glycosphingolipid metabolism.
@ast
Salvage pathways in glycosphingolipid metabolism.
@en
type
label
Salvage pathways in glycosphingolipid metabolism.
@ast
Salvage pathways in glycosphingolipid metabolism.
@en
prefLabel
Salvage pathways in glycosphingolipid metabolism.
@ast
Salvage pathways in glycosphingolipid metabolism.
@en
P2093
P1433
P1476
Salvage pathways in glycosphingolipid metabolism.
@en
P2093
P304
P356
10.1016/S0300-9084(03)00047-6
P577
2003-03-01T00:00:00Z